A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose.

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected revenue range to $1.6 – $2.0 billion Improves 2025 expected GAAP operating ...

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: A precisely timed mRNA shot could help many cancer patients live longer.

Telemark Asset Management, LLC established a new position in Moderna ( MRNA 1.26%), acquiring 500,000 shares valued at approximately $12.91 million as of September 30, 2025, according to a November 10 ...

Commitment to U.S. Manufacturing – GeoVax is advancing continuous cell line manufacturing to expand supply, reduce costs, and support U.S. preparedness, aligning with federal initiatives to strengthen ...

BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“BioNexus” or the “Company”), a biotechnology company advancing precision diagnostics and gene-based technologies across Asia and the U.S., today announced that ...

The investment, the budget says, ought to attract more than 1,000 international researchers to the country. It will require a ...

Bybit, the world's second-largest cryptocurrency exchange by trading volume, is thrilled to announce that its On-Chain Earn platform has recently added support for Polkadot (DOT) staking. This new ...

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...

The greater part of third quarter earnings results are in the rearview mirror, though investors this week are looking to ...

Several letter writers push back against mockery of No Kings Rally, local candidates thank voters, a call for impact fees on ...

Generative AI is being used to design molecules and predict properties. In clinical trials, AI is helpful in selecting ...